Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01272245. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01542684. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS
ClinicalTrials.gov study NCT04623996. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML
ClinicalTrials.gov study NCT01957644. IPD Sharing: Not stated. Countries: 2. Publications: 0.
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML
ClinicalTrials.gov study NCT00774046. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
ClinicalTrials.gov study NCT02000154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LBH589 in Refractory Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00594230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
ClinicalTrials.gov study NCT01191749. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.
ClinicalTrials.gov study NCT02159040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01019317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
ClinicalTrials.gov study NCT02002936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01034657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN
ClinicalTrials.gov study NCT04639024. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01222195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 Therapy for MDS After Hypomethylating Agent Failure
ClinicalTrials.gov study NCT03957876. IPD Sharing: NO. Countries: 1. Publications: 0.
Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure
ClinicalTrials.gov study NCT02159872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
2 Arm Study of Clofarabine IV in MDS Patients
ClinicalTrials.gov study NCT00422032. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02929498. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)
ClinicalTrials.gov study NCT00704704. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
ClinicalTrials.gov study NCT01011283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.